Viral Vector and Plasmid DNA Manufacturing Market Report 2026: 130+ Players Drive Shift Toward Integrated Commercial-Scale Manufacturing - Industry Trends and Global Forecasts ...

The viral vector and plasmid DNA manufacturing market offers growth opportunities in gene therapies, contract manufacturing, and emerging markets like Asia-Pacific. Key trends include rising demand ...

Viral Vectors & Plasmid DNA Manufacturing Market Size Worth USD 29.82 Bn by 2035 Growing Demand for Gene and Cell Therapies Drives the Market

The globe viral vectors & plasmid DNA manufacturing market size is expected to be lead USD 29.82 billion by 2035, increasing ...
The New England Journal of Medicine

AAV9-Mediated Gene Therapy for Infantile-Onset Pompe’s Disease

Four patients with infantile-onset Pompe’s disease received a single intravenous injection of an adeno-associated virus serotype 9 vector carrying codon-optimized complementary DNA encoding human acid ...